Global and Japan Pediatric Vaccines Market Insights, Forecast to 2026

Publisher Name :
Date: 25-Sep-2020
No. of pages: 143
Inquire Before Buying

Pediatric Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Pediatric Vaccines market is segmented into

- Diphtheria

- Influenza

- Hepatitis

- Pneumococcal Diseases

- Meningococcal Diseases

- Others

Segment by Application, the Pediatric Vaccines market is segmented into

- Newborn

- Infant

- Child

- Dolescent

Regional and Country-level Analysis

The Pediatric Vaccines market is analysed and market size information is provided by regions (countries).

The key regions covered in the Pediatric Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Pediatric Vaccines Market Share Analysis

Pediatric Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pediatric Vaccines business, the date to enter into the Pediatric Vaccines market, Pediatric Vaccines product introduction, recent developments, etc.

The major vendors covered:

- GlaxoSmithKline

- Merck

- Pfizer

- Sanofi

- AstraZeneca

- Novartis

- Takeda Pharmaceutical

- Bavarian Nordic

- Baxter

- LG Life Sciences

- Lupin

- S K Chemicals

- Mitsubishi Tanabe Pharma

- Janssen

- Shenzhen Kangtai Biological Products

- Sinovac Biotech

- Bharat Biotech

- Crucell

- Dynavax

- Serum Institute of India

Global and Japan Pediatric Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pediatric Vaccines Product Introduction
1.2 Market Segments
1.3 Key Pediatric Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pediatric Vaccines Market Size Growth Rate by Type
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Others
1.5 Market by Application
1.5.1 Global Pediatric Vaccines Market Size Growth Rate by Application
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.5.5 Dolescent
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Pediatric Vaccines Revenue 2015-2026
2.1.2 Global Pediatric Vaccines Sales 2015-2026
2.2 Global Pediatric Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pediatric Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Pediatric Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pediatric Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pediatric Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pediatric Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Pediatric Vaccines Revenue Forecast by Region (2021-2026)
3 Global Pediatric Vaccines Competitor Landscape by Players
3.1 Global Top Pediatric Vaccines Sales by Manufacturers
3.1.1 Global Pediatric Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Pediatric Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pediatric Vaccines Manufacturers by Revenue
3.2.1 Global Pediatric Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Pediatric Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pediatric Vaccines Revenue in 2019
3.2.5 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pediatric Vaccines Price by Manufacturers
3.4 Global Pediatric Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatric Vaccines Market Size by Type (2015-2020)
4.1.1 Global Pediatric Vaccines Sales by Type (2015-2020)
4.1.2 Global Pediatric Vaccines Revenue by Type (2015-2020)
4.1.3 Pediatric Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pediatric Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pediatric Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Pediatric Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Pediatric Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pediatric Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pediatric Vaccines Market Size by Application (2015-2020)
5.1.1 Global Pediatric Vaccines Sales by Application (2015-2020)
5.1.2 Global Pediatric Vaccines Revenue by Application (2015-2020)
5.1.3 Pediatric Vaccines Price by Application (2015-2020)
5.2 Pediatric Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pediatric Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Pediatric Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pediatric Vaccines Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Pediatric Vaccines Market Size YoY Growth 2015-2026
6.1.1 Japan Pediatric Vaccines Sales YoY Growth 2015-2026
6.1.2 Japan Pediatric Vaccines Revenue YoY Growth 2015-2026
6.1.3 Japan Pediatric Vaccines Market Share in Global Market 2015-2026
6.2 Japan Pediatric Vaccines Market Size by Players (International and Local Players)
6.2.1 Japan Top Pediatric Vaccines Players by Sales (2015-2020)
6.2.2 Japan Top Pediatric Vaccines Players by Revenue (2015-2020)
6.3 Japan Pediatric Vaccines Historic Market Review by Type (2015-2020)
6.3.1 Japan Pediatric Vaccines Sales Market Share by Type (2015-2020)
6.3.2 Japan Pediatric Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 Japan Pediatric Vaccines Price by Type (2015-2020)
6.4 Japan Pediatric Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Pediatric Vaccines Sales Forecast by Type (2021-2026)
6.4.2 Japan Pediatric Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 Japan Pediatric Vaccines Price Forecast by Type (2021-2026)
6.5 Japan Pediatric Vaccines Historic Market Review by Application (2015-2020)
6.5.1 Japan Pediatric Vaccines Sales Market Share by Application (2015-2020)
6.5.2 Japan Pediatric Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 Japan Pediatric Vaccines Price by Application (2015-2020)
6.6 Japan Pediatric Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Pediatric Vaccines Sales Forecast by Application (2021-2026)
6.6.2 Japan Pediatric Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 Japan Pediatric Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pediatric Vaccines Market Size YoY Growth 2015-2026
7.2 North America Pediatric Vaccines Market Facts & Figures by Country
7.2.1 North America Pediatric Vaccines Sales by Country (2015-2020)
7.2.2 North America Pediatric Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pediatric Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Pediatric Vaccines Market Facts & Figures by Country
8.2.1 Europe Pediatric Vaccines Sales by Country
8.2.2 Europe Pediatric Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pediatric Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pediatric Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Pediatric Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Pediatric Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pediatric Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Pediatric Vaccines Market Facts & Figures by Country
10.2.1 Latin America Pediatric Vaccines Sales by Country
10.2.2 Latin America Pediatric Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pediatric Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Pediatric Vaccines Sales by Country
11.2.2 Middle East and Africa Pediatric Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Pediatric Vaccines Products Offered
12.2.5 Merck Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Description and Business Overview
12.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Pediatric Vaccines Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Pediatric Vaccines Products Offered
12.4.5 Sanofi Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Description and Business Overview
12.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AstraZeneca Pediatric Vaccines Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Pediatric Vaccines Products Offered
12.6.5 Novartis Recent Development
12.7 Takeda Pharmaceutical
12.7.1 Takeda Pharmaceutical Corporation Information
12.7.2 Takeda Pharmaceutical Description and Business Overview
12.7.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Takeda Pharmaceutical Pediatric Vaccines Products Offered
12.7.5 Takeda Pharmaceutical Recent Development
12.8 Bavarian Nordic
12.8.1 Bavarian Nordic Corporation Information
12.8.2 Bavarian Nordic Description and Business Overview
12.8.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bavarian Nordic Pediatric Vaccines Products Offered
12.8.5 Bavarian Nordic Recent Development
12.9 Baxter
12.9.1 Baxter Corporation Information
12.9.2 Baxter Description and Business Overview
12.9.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Baxter Pediatric Vaccines Products Offered
12.9.5 Baxter Recent Development
12.10 LG Life Sciences
12.10.1 LG Life Sciences Corporation Information
12.10.2 LG Life Sciences Description and Business Overview
12.10.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
12.10.4 LG Life Sciences Pediatric Vaccines Products Offered
12.10.5 LG Life Sciences Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Pediatric Vaccines Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 S K Chemicals
12.12.1 S K Chemicals Corporation Information
12.12.2 S K Chemicals Description and Business Overview
12.12.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 S K Chemicals Products Offered
12.12.5 S K Chemicals Recent Development
12.13 Mitsubishi Tanabe Pharma
12.13.1 Mitsubishi Tanabe Pharma Corporation Information
12.13.2 Mitsubishi Tanabe Pharma Description and Business Overview
12.13.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Mitsubishi Tanabe Pharma Products Offered
12.13.5 Mitsubishi Tanabe Pharma Recent Development
12.14 Janssen
12.14.1 Janssen Corporation Information
12.14.2 Janssen Description and Business Overview
12.14.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Janssen Products Offered
12.14.5 Janssen Recent Development
12.15 Shenzhen Kangtai Biological Products
12.15.1 Shenzhen Kangtai Biological Products Corporation Information
12.15.2 Shenzhen Kangtai Biological Products Description and Business Overview
12.15.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Shenzhen Kangtai Biological Products Products Offered
12.15.5 Shenzhen Kangtai Biological Products Recent Development
12.16 Sinovac Biotech
12.16.1 Sinovac Biotech Corporation Information
12.16.2 Sinovac Biotech Description and Business Overview
12.16.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Sinovac Biotech Products Offered
12.16.5 Sinovac Biotech Recent Development
12.17 Bharat Biotech
12.17.1 Bharat Biotech Corporation Information
12.17.2 Bharat Biotech Description and Business Overview
12.17.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Bharat Biotech Products Offered
12.17.5 Bharat Biotech Recent Development
12.18 Crucell
12.18.1 Crucell Corporation Information
12.18.2 Crucell Description and Business Overview
12.18.3 Crucell Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Crucell Products Offered
12.18.5 Crucell Recent Development
12.19 Dynavax
12.19.1 Dynavax Corporation Information
12.19.2 Dynavax Description and Business Overview
12.19.3 Dynavax Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Dynavax Products Offered
12.19.5 Dynavax Recent Development
12.20 Serum Institute of India
12.20.1 Serum Institute of India Corporation Information
12.20.2 Serum Institute of India Description and Business Overview
12.20.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Serum Institute of India Products Offered
12.20.5 Serum Institute of India Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pediatric Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pediatric Vaccines Market Segments
Table 2. Ranking of Global Top Pediatric Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pediatric Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diphtheria
Table 5. Major Manufacturers of Influenza
Table 6. Major Manufacturers of Hepatitis
Table 7. Major Manufacturers of Pneumococcal Diseases
Table 8. Major Manufacturers of Meningococcal Diseases
Table 9. Major Manufacturers of Others
Table 10. Global Pediatric Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Pediatric Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Pediatric Vaccines Sales by Regions 2015-2020 (K Units)
Table 13. Global Pediatric Vaccines Sales Market Share by Regions (2015-2020)
Table 14. Global Pediatric Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Pediatric Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 16. Global Pediatric Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Pediatric Vaccines Sales Share by Manufacturers (2015-2020)
Table 18. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Vaccines as of 2019)
Table 20. Pediatric Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pediatric Vaccines Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pediatric Vaccines Price (2015-2020) (USD/Unit)
Table 23. Pediatric Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pediatric Vaccines Product Type
Table 25. Date of International Manufacturers Enter into Pediatric Vaccines Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pediatric Vaccines Sales by Type (2015-2020) (K Units)
Table 28. Global Pediatric Vaccines Sales Share by Type (2015-2020)
Table 29. Global Pediatric Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pediatric Vaccines Revenue Share by Type (2015-2020)
Table 31. Pediatric Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Pediatric Vaccines Sales Share by Type (2021-2026)
Table 33. Global Pediatric Vaccines Sales by Application (2015-2020) (K Units)
Table 34. Global Pediatric Vaccines Sales Share by Application (2015-2020)
Table 35. Global Pediatric Vaccines Sales Share by Application (2021-2026)
Table 36. Global Pediatric Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Pediatric Vaccines Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Pediatric Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 39. Japan Pediatric Vaccines Sales (K Units) of Key Companies (2015-2020)
Table 40. Japan Pediatric Vaccines Sales Share by Company (2015-2020)
Table 41. Japan Pediatric Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 42. Japan Pediatric Vaccines Sales (K Units) by Type (2015-2020)
Table 43. Japan Pediatric Vaccines Sales Share by Type (2015-2020)
Table 44. Japan Pediatric Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. Japan Pediatric Vaccines Price (K Units) by Type (2015-2020)
Table 46. Japan Pediatric Vaccines Sales (K Units) by Type (2021-2026)
Table 47. Japan Pediatric Vaccines Sales Share by Type (2021-2026)
Table 48. Japan Pediatric Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. Japan Pediatric Vaccines Revenue Share by Type (2021-2026)
Table 50. Japan Pediatric Vaccines Price (K Units) by Type (2021-2026)
Table 51. Japan Pediatric Vaccines Sales (K Units) by Application (2015-2020)
Table 52. Japan Pediatric Vaccines Sales Share by Application (2015-2020)
Table 53. Japan Pediatric Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. Japan Pediatric Vaccines Sales (K Units) by Application (2021-2026)
Table 55. Japan Pediatric Vaccines Sales Share by Application (2021-2026)
Table 56. Japan Pediatric Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Japan Pediatric Vaccines Revenue Share by Application (2021-2026)
Table 58. North America Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 59. North America Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 60. North America Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 62. Europe Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 63. Europe Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 64. Europe Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Pediatric Vaccines Sales by Region (2015-2020) (K Units)
Table 67. Asia Pacific Pediatric Vaccines Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Pediatric Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Pediatric Vaccines Revenue Market Share by Region (2015-2020)
Table 70. Latin America Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 71. Latin America Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 75. Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 78. GlaxoSmithKline Corporation Information
Table 79. GlaxoSmithKline Description and Business Overview
Table 80. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. GlaxoSmithKline Pediatric Vaccines Product
Table 82. GlaxoSmithKline Recent Development
Table 83. Merck Corporation Information
Table 84. Merck Description and Business Overview
Table 85. Merck Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Merck Product
Table 87. Merck Recent Development
Table 88. Pfizer Corporation Information
Table 89. Pfizer Description and Business Overview
Table 90. Pfizer Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Pfizer Product
Table 92. Pfizer Recent Development
Table 93. Sanofi Corporation Information
Table 94. Sanofi Description and Business Overview
Table 95. Sanofi Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Sanofi Product
Table 97. Sanofi Recent Development
Table 98. AstraZeneca Corporation Information
Table 99. AstraZeneca Description and Business Overview
Table 100. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. AstraZeneca Product
Table 102. AstraZeneca Recent Development
Table 103. Novartis Corporation Information
Table 104. Novartis Description and Business Overview
Table 105. Novartis Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Novartis Product
Table 107. Novartis Recent Development
Table 108. Takeda Pharmaceutical Corporation Information
Table 109. Takeda Pharmaceutical Description and Business Overview
Table 110. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Takeda Pharmaceutical Product
Table 112. Takeda Pharmaceutical Recent Development
Table 113. Bavarian Nordic Corporation Information
Table 114. Bavarian Nordic Description and Business Overview
Table 115. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Bavarian Nordic Product
Table 117. Bavarian Nordic Recent Development
Table 118. Baxter Corporation Information
Table 119. Baxter Description and Business Overview
Table 120. Baxter Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Baxter Product
Table 122. Baxter Recent Development
Table 123. LG Life Sciences Corporation Information
Table 124. LG Life Sciences Description and Business Overview
Table 125. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. LG Life Sciences Product
Table 127. LG Life Sciences Recent Development
Table 128. Lupin Corporation Information
Table 129. Lupin Description and Business Overview
Table 130. Lupin Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Lupin Product
Table 132. Lupin Recent Development
Table 133. S K Chemicals Corporation Information
Table 134. S K Chemicals Description and Business Overview
Table 135. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. S K Chemicals Product
Table 137. S K Chemicals Recent Development
Table 138. Mitsubishi Tanabe Pharma Corporation Information
Table 139. Mitsubishi Tanabe Pharma Description and Business Overview
Table 140. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. Mitsubishi Tanabe Pharma Product
Table 142. Mitsubishi Tanabe Pharma Recent Development
Table 143. Janssen Corporation Information
Table 144. Janssen Description and Business Overview
Table 145. Janssen Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Janssen Product
Table 147. Janssen Recent Development
Table 148. Shenzhen Kangtai Biological Products Corporation Information
Table 149. Shenzhen Kangtai Biological Products Description and Business Overview
Table 150. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 151. Shenzhen Kangtai Biological Products Product
Table 152. Shenzhen Kangtai Biological Products Recent Development
Table 153. Sinovac Biotech Corporation Information
Table 154. Sinovac Biotech Description and Business Overview
Table 155. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 156. Sinovac Biotech Product
Table 157. Sinovac Biotech Recent Development
Table 158. Bharat Biotech Corporation Information
Table 159. Bharat Biotech Description and Business Overview
Table 160. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 161. Bharat Biotech Product
Table 162. Bharat Biotech Recent Development
Table 163. Crucell Corporation Information
Table 164. Crucell Description and Business Overview
Table 165. Crucell Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 166. Crucell Product
Table 167. Crucell Recent Development
Table 168. Dynavax Corporation Information
Table 169. Dynavax Description and Business Overview
Table 170. Dynavax Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 171. Dynavax Product
Table 172. Dynavax Recent Development
Table 173. Serum Institute of India Corporation Information
Table 174. Serum Institute of India Description and Business Overview
Table 175. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 176. Serum Institute of India Product
Table 177. Serum Institute of India Recent Development
Table 178. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 179. Key Challenges
Table 180. Market Risks
Table 181. Main Points Interviewed from Key Pediatric Vaccines Players
Table 182. Pediatric Vaccines Customers List
Table 183. Pediatric Vaccines Distributors List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Vaccines Product Picture
Figure 2. Global Pediatric Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Diphtheria Product Picture
Figure 4. Influenza Product Picture
Figure 5. Hepatitis Product Picture
Figure 6. Pneumococcal Diseases Product Picture
Figure 7. Meningococcal Diseases Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pediatric Vaccines Sales Market Share by Application in 2020 & 2026
Figure 10. Newborn
Figure 11. Infant
Figure 12. Child
Figure 13. Dolescent
Figure 14. Pediatric Vaccines Report Years Considered
Figure 15. Global Pediatric Vaccines Market Size 2015-2026 (US$ Million)
Figure 16. Global Pediatric Vaccines Sales 2015-2026 (K Units)
Figure 17. Global Pediatric Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Pediatric Vaccines Sales Market Share by Region (2015-2020)
Figure 19. Global Pediatric Vaccines Sales Market Share by Region in 2019
Figure 20. Global Pediatric Vaccines Revenue Market Share by Region (2015-2020)
Figure 21. Global Pediatric Vaccines Revenue Market Share by Region in 2019
Figure 22. Global Pediatric Vaccines Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Pediatric Vaccines Revenue in 2019
Figure 24. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Pediatric Vaccines Sales Market Share by Type (2015-2020)
Figure 26. Global Pediatric Vaccines Sales Market Share by Type in 2019
Figure 27. Global Pediatric Vaccines Revenue Market Share by Type (2015-2020)
Figure 28. Global Pediatric Vaccines Revenue Market Share by Type in 2019
Figure 29. Global Pediatric Vaccines Market Share by Price Range (2015-2020)
Figure 30. Global Pediatric Vaccines Sales Market Share by Application (2015-2020)
Figure 31. Global Pediatric Vaccines Sales Market Share by Application in 2019
Figure 32. Global Pediatric Vaccines Revenue Market Share by Application (2015-2020)
Figure 33. Global Pediatric Vaccines Revenue Market Share by Application in 2019
Figure 34. Japan Pediatric Vaccines Sales Growth Rate 2015-2026 (K Units)
Figure 35. Japan Pediatric Vaccines Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. Japan Pediatric Vaccines Market Share in Global Market 2015-2026
Figure 37. Japan 5 and 10 Largest Pediatric Vaccines Players Market Share by Revenue in Pediatric Vaccines in 2019
Figure 38. Japan Pediatric Vaccines Revenue Share by Type (2015-2020)
Figure 39. Japan Pediatric Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 40. Japan Pediatric Vaccines Revenue Share by Application (2015-2020)
Figure 41. Japan Pediatric Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 43. North America Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Pediatric Vaccines Sales Market Share by Country in 2019
Figure 45. North America Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 46. U.S. Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.S. Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Canada Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 51. Europe Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Pediatric Vaccines Sales Market Share by Country in 2019
Figure 53. Europe Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 54. Germany Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 55. Germany Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 57. France Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. U.K. Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Italy Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Russia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 65. Asia Pacific Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Pediatric Vaccines Sales Market Share by Region in 2019
Figure 67. Asia Pacific Pediatric Vaccines Revenue Market Share by Region in 2019
Figure 68. China Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. China Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Pedia
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs